An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are urged to message these profiles directly for source information, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where groups with thousands of members share comparison images, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Worries
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of uncertain source.
Some experts said the popularity for retatrutide could be connected to the rising cost of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Some content creators try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to penalties, prosecution or prison.
Service Response and Content Removal
Based on TikTok, the platform has removed problematic material and banned related hashtags and query recommendations. The company stated it was committed to keeping the platform safe and investing in strengthening compliance measures.
Online Trading Activities
Research also discovered groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, populated with photos of weight loss, positive reviews and step-by-step guides for preparing or administering at home.
Within minutes of joining one group, a seller shared contact information, where most transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.
Item Information and Costs
Within these groups, posts show black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for Telegram stated it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her team has already encountered patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental product not yet authorized … may subject patients to possibly serious health risks”.
